Timing and trajectory of <i>BCR::ABL1-</i>driven chronic myeloid leukaemia
Nature, Published online: 09 April 2025; doi:10.1038/s41586-025-08817-2Explosive growth is attributed to the BCR::ABL1 gene 3–14 years before diagnosis of chronic myeloid leukaemia, highlighting the oncogenic potency of gene fusion and the slow and sequential trajectories of most other cancers.
Nature, Published online: 09 April 2025; doi:10.1038/s41586-025-08817-2Explosive growth is attributed to the BCR::ABL1 gene 3–14 years before diagnosis of chronic myeloid leukaemia, highlighting the oncogenic potency of gene fusion and the slow and sequential trajectories of most other cancers.
